Blume Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-37
| Closed | -$2.88K | – | 325 |
|
|
2024
Q3 | $2.88K | Buy |
+37
| New | +$2.88K | ﹤0.01% | 321 |
|
|
2024
Q1 | – | Sell |
-50
| Closed | -$3.37K | – | 313 |
|
|
2023
Q4 | $3.37K | Sell |
50
-13
| -21% | -$876 | ﹤0.01% | 285 |
|
|
2023
Q3 | $4.27K | Hold |
63
| – | – | ﹤0.01% | 277 |
|
|
2023
Q2 | $4.51K | Buy |
+63
| New | +$4.51K | ﹤0.01% | 281 |
|
|
2019
Q1 | – | Sell |
-500
| Closed | -$19K | – | 224 |
|
|
2018
Q4 | $19K | Buy |
+500
| New | +$19K | 0.01% | 164 |
|